Genomewide association analyses of electrophysiological endophenotypes for schizophrenia and psychotic bipolar disorders: A preliminary report

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 3, 2015, Pages 151-161

  Hall, Mei Hua ^a,b   Chen, Chia Yen ^b   Cohen, Bruce M ^a   Spencer, Kevin M ^d   Levy, Deborah L ^a   Öngür, Dost ^a   Smoller, Jordan W ^b,c  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bipolar disorders; Endophenotypes; Event related potentials; Genowide assoication; Polygentic risk score; Schizophrenia

Indexed keywords

AMFEBUTAMONE; CLONAZEPAM; LAMOTRIGINE; LITHIUM CARBONATE; LORAZEPAM; VALPROATE SEMISODIUM;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; CHROMOSOME 14; CHROMOSOME 4; CONTROLLED STUDY; DSM-IV; ELECTROPHYSIOLOGICAL PROCEDURES; ENDOPHENOTYPE; EVENT RELATED POTENTIAL; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SENSORY GATING; SIGNAL PROCESSING; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; ELECTROPHYSIOLOGY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; PATHOLOGY; PROCEDURES; PROGNOSIS;

ADULT; BIPOLAR DISORDER; ELECTROPHYSIOLOGY; ENDOPHENOTYPES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; PROGNOSIS; SCHIZOPHRENIA;

EID: 84925660486     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32298     Document Type: Article

References (55)

1. Arai J, Natsume K. 2006. The properties of carbachol-induced beta oscillation in rat hippocampal slices. Neurosci Res 54:(2):95-103.
2. Bramon E, McDonald C, Croft RJ, Landau S, Filbey F, Gruzelier JH, Sham PC, Frangou S, Murray RM. 2005. Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study. Neuroimage 27:(4):960-968.
3. Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S. 2004. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 70:(2-3):315-329.
4. Clementz BA, Geyer MA, Braff DL. 1998. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry 155:(12):1691-1694.
5. Cross-Disorder Group of the Psychiatric Genomics C, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA, Anjorin A, Anney R, Anttila V, Arking DE, Asherson P, Azevedo MH, Backlund L, Badner JA, Bailey AJ, Banaschewski T, Barchas JD, Barnes MR, Barrett TB, Bass N, Battaglia A, Bauer M, Bayes M, Bellivier F, Bergen SE, Berrettini W, Betancur C, Bettecken T, Biederman J, Binder EB, Black DW, Blackwood DH, Bloss CS, Boehnke M, Boomsma DI, Breen G, Breuer R, Bruggeman R, Cormican P, Buccola NG, Buitelaar JK, Bunney WE, Buxbaum JD, Byerley WF, Byrne EM, Caesar S, Cahn W, Cantor RM, Casas M, Chakravarti A, Chambert K, Choudhury K, Cichon S, Cloninger CR, Collier DA, Cook EH, Coon H, Cormand B, Corvin A, Coryell WH, Craig DW, Craig IW, Crosbie J, Cuccaro ML, Curtis D, Czamara D, Datta S, Dawson G, Day R, De Geus EJ, Degenhardt F, Djurovic S, Donohoe GJ, Doyle AE, Duan J, Dudbridge F, Duketis E, Ebstein RP, Edenberg HJ, Elia J, Ennis S, Etain B, Fanous A, Farmer AE, Ferrier IN, Flickinger M, Fombonne E, Foroud T, Frank J, Franke B, Fraser C, Freedman R, Freimer NB, Freitag CM, Friedl M, Frisen L, Gallagher L, Gejman PV, Georgieva L, Gershon ES, Geschwind DH, Giegling I, Gill M, Gordon SD, Gordon-Smith K, Green EK, Greenwood TA, Grice DE, Gross M, Grozeva D, Guan W, Gurling H, De Haan L, Haines JL, Hakonarson H, Hallmayer J, Hamilton SP, Hamshere ML, Hansen TF, Hartmann AM, Hautzinger M, Heath AC, Henders AK, Herms S, Hickie IB, Hipolito M, Hoefels S, Holmans PA, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hultman CM, Hus V, Ingason A, Ising M, Jamain S, Jones EG, Jones I, Jones L, Tzeng JY, Kahler AK, Kahn RS, Kandaswamy R, Keller MC, Kennedy JL, Kenny E, Kent L, Kim Y, Kirov GK, Klauck SM, Klei L, Knowles JA, Kohli MA, Koller DL, Konte B, Korszun A, Krabbendam L, Krasucki R, Kuntsi J, Kwan P, Landen M, Langstrom N, Lathrop M, Lawrence J, Lawson WB, Leboyer M, Ledbetter DH, Lee PH, Lencz T, Lesch KP, Levinson DF, Lewis CM, Li J, Lichtenstein P, Lieberman JA, Lin DY, Linszen DH, Liu C, Lohoff FW, Loo SK, Lord C, Lowe JK, Lucae S, MacIntyre DJ, Madden PA, Maestrini E, Magnusson PK, Mahon PB, Maier W, Malhotra AK, Mane SM, Martin CL, Martin NG, Mattheisen M, Matthews K, Mattingsdal M, McCarroll SA, McGhee KA, McGough JJ, McGrath PJ, McGuffin P, McInnis MG, McIntosh A, McKinney R, McLean AW, McMahon FJ, McMahon WM, McQuillin A, Medeiros H, Medland SE, Meier S, Melle I, Meng F, Meyer J, Middeldorp CM, Middleton L, Milanova V, Miranda A, Monaco AP, Montgomery GW, Moran JL, Moreno-De-Luca D, Morken G, Morris DW, Morrow EM, Moskvina V, Muglia P, Muhleisen TW, Muir WJ, Muller-Myhsok B, Murtha M, Myers RM, Myin-Germeys I, Neale MC, Nelson SF, Nievergelt CM, Nikolov I, Nimgaonkar V, Nolen WA, Nothen MM, Nurnberger JI, Nwulia EA, Nyholt DR, O'Dushlaine C, Oades RD, Olincy A, Oliveira G, Olsen L, Ophoff RA, Osby U, Owen MJ, Palotie A, Parr JR, Paterson AD, Pato CN, Pato MT, Penninx BW, Pergadia ML, Pericak-Vance MA, Pickard BS, Pimm J, Piven J, Posthuma D, Potash JB, Poustka F, Propping P, Puri V, Quested DJ, Quinn EM, Ramos-Quiroga JA, Rasmussen HB, Raychaudhuri S, Rehnstrom K, Reif A, Ribases M, Rice JP, Rietschel M, Roeder K, Roeyers H, Rossin L, Rothenberger A, Rouleau G, Ruderfer D, Rujescu D, Sanders AR, Sanders SJ, Santangelo SL, Sergeant JA, Schachar R, Schalling M, Schatzberg AF, Scheftner WA, Schellenberg GD, Scherer SW, Schork NJ, Schulze TG, Schumacher J, Schwarz M, Scolnick E, Scott LJ, Shi J, Shilling PD, Shyn SI, Silverman JM, Slager SL, Smalley SL, Smit JH, Smith EN, Sonuga-Barke EJ, St Clair D, State M, Steffens M, Steinhausen HC, Strauss JS, Strohmaier J, Stroup TS, Sutcliffe JS, Szatmari P, Szelinger S, Thirumalai S, Thompson RC, Todorov AA, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Van Os J, Vicente AM, Vieland VJ, Vincent JB, Visscher PM, Walsh CA, Wassink TH, Watson SJ, Weissman MM, Werge T, Wienker TF, Wijsman EM, Willemsen G, Williams N, Willsey AJ, Witt SH, Xu W, Young AH, Yu TW, Zammit S, Zandi PP, Zhang P, Zitman FG, Zollner S, International Inflammatory Bowel Disease Genetics C, Devlin B, Kelsoe JR, Sklar P, Daly MJ, O'Donovan MC, Craddock N, Sullivan PF, Smoller JW, Kendler KS, Wray NR. 2013a. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45:(9):984-994.
6. Cross-Disorder Group of the Psychiatric Genomics C, Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI, Ripke S, Santangelo S, Sullivan PF. 2013b. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381:(9875):1371-1379.
7. Delaneau O, Marchini J, Zagury JF. 2012. A linear complexity phasing method for thousands of genomes. Nature methods 9:(2):179-181.
8. First MB, Spitzer RL, Gibbon M, Williams JBW. 1997. Structured clinical interview for DSM-IV Axis I Disorders (SCID). New York: New York State Psychiatric Institute, Biometrics Research.
9. Freedman R, Adler LE, Bickford P, Byerley W, Coon H, Cullum CM, Griffith JM, Harris JG, Leonard S, Miller C, et al. 1994. Schizophrenia and nicotinic receptors. Harv Rev Psychiatry 2:(4):179-192.
10. Freedman R, Adler LE, Myles-Worsley M, Nagamoto HT, Miller C, Kisley M, McRae K, Cawthra E, Waldo M. 1996. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. Arch Gen Psychiatry 53:(12):1114-1121.
11. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W. 1997. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:(2):587-592.
12. Gratton G, Coles MG, Donchin E. 1983. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 55:(4):468-484.
13. Hall M-H, Rijsdijk FV, Picchioni M, Schulze K, Ettinger U, Toulopoulou T, Murray R, Sham P. 2007. Substantial shared genetic influences on schizophrenia and event-related potentials. Am J Psychiatry 164:804-812.
14. Hall MH, Levy DL, Salisbury DF, Haddad S, Gallagher PJ, Lohan M, Cohen BM, Ongur D, Smoller JW. 2013. Neurohysiologic Effects of GWAS Derived Schizophrenia and Bipolar Risk Variants. Am J Med Genet B Neuropsychiatr Genet 165B:(1):9-18.
15. Hall MH, Schulze K, Rijsdijk F, Kalidindi S, McDonald C, Bramon E, Murray RM, Sham P. 2009a. Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol Med 39:(8):1277-1287.
16. Hall MH, Schulze K, Rijsdijk F, Picchioni M, Ettinger U, Bramon E, Freedman R, Murray RM, Sham P. 2006. Heritability and Reliability of P300, P50 and Duration Mismatch Negativity. Behavior genetics 36:(6):845-857.
17. Hall MH, Schulze K, Sham P, Kalidindi S, McDonald C, Bramon E, Levy DL, Murray RM, Rijsdijk F. 2008. Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: A combined twin and family study. Am J Med Genet B Neuropsychiatr Genet 147B:(5):619-627.
18. Hall MH, Smoller JW, Cook NR, Schulze K, Hyoun Lee, Taylor P, Bramon G, Coleman E, Murray MJ, Salisbury RM, Levy DF. 2012. Patterns of deficits in brain function in bipolar disorder and schizophrenia: A cluster analytic study. Psychiatry Res 200:(2-3):272-280.
19. Hall MH, Spencer KM, Schulze K, McDonald C, Kalidindi S, Kravariti E, Kane F, Murray RM, Bramon E, Sham P, Rijsdijk F. 2011a. The genetic and environmental influences of event- related gamma oscillations on bipolar disorder. Bipolar Disord I 13:(13):260-271.
20. Hall MH, Taylor G, Salisbury DF, Levy DL. 2011b. Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives. Schizophr Bull 37:(6):1187-1199.
21. Hall MH, Taylor G, Sham P, Schulze K, Rijsdijk F, Picchioni M, Toulopoulou T, Ettinger U, Bramon E, Murray RM, Salisbury DF. 2009b. The early auditory gamma-band response is heritable and a putative endophenotype of schizophrenia. Schizophr Bull 37: 778-787.
22. Howie B, Marchini J, Stephens M. 2011. Genotype imputation with thousands of genomes. G3 1:(6):457-470.
23. Kwon JS, O'Donnell BF, Wallenstein GV, Greene RW, Hirayasu Y, Nestor PG, Hasselmo ME, Potts GF, Shenton ME, McCarley RW. 1999. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch Gen Psychiatry 56:(11):1001-1005.
24. Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse P, Lundervold A, Steen VM, John M, Espeseth T, Raikkonen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Donohoe G, Morris D, Corvin A, Gill M, Pendleton N, Iwata N, Darvasi A, Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK. 2014. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: A report from the Cognitive Genomics consorTium (COGENT). Mol Psychiatry 19:(2):168-174.
25. Luck SJ. 2005. An introduction to the event-related potential technique. The MIT Press, Cambridge, Massachusetts, ISBN 0-262-12277-4.
26. McCarthy G, Donchin E. 1981. A metric for thought: A comparison of P300 latency and reaction time. Science 211:(4477):77-80.
27. Muir WJ, St Clair DM, Blackwood DH. 1991. Long-latency auditory event-related potentials in schizophrenia and in bipolar and unipolar affective disorder. Psychol Med 21:(4):867-879.
28. O'Donnell BF, Vohs JL, Krishnan GP, Rass O, Hetrick WP, Morzorati SL. 2013. The auditory steady-state response (ASSR): A translational biomarker for schizophrenia. Suppl Clin Neurophysiol 62: 101-112.
29. Olincy A, Martin L. 2005. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry 162:(1):43-49.
30. Perez VB, Roach BJ, Woods SW, Srihari VH, McGlashan TH, Ford JM, Mathalon DH. 2013. Early auditory gamma-band responses in patients at clinical high risk for schizophrenia. Suppl Clin Neurophysiol 62: 147-162.
31. Polich J, Kok A. 1995. Cognitive and biological determinants of P300: An integrative review. Biolo Psychol 41:(2):103-146.
32. Porjesz B, Almasy L, Edenberg HJ, Wang K, Chorlian DB, Foroud T, Goate A, Rice JP, O'Connor SJ, Rohrbaugh J, Kuperman S, Bauer LO, Crowe RR, Schuckit MA, Hesselbrock V, Conneally PM, Tischfield JA, Li T-K, Reich T, Begleiter H. 2002. Linkage disequilibrium between the beta frequency of the human EEG and a GABAA receptor gene locus. Proc Natl Acad Sci USA 99:(6):3729-3733.
33. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:(8):904-909.
34. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:(3):559-575.
35. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:(7256):748-752.
36. Quednow BB, Brinkmeyer J, Mobascher A, Nothnagel M, Musso F, Grunder G, Savary N, Petrovsky N, Frommann I, Lennertz L, Spreckelmeyer KN, Wienker TF, Dahmen N, Thuerauf N, Clepce M, Kiefer F, Majic T, Mossner R, Maier W, Gallinat J, Diaz-Lacava A, Toliat MR, Thiele H, Nurnberg P, Wagner M, Winterer G. 2012. Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating. Proc Natl Acad Sci USA 109:(16):6271-6276.
37. Rass O, Krishnan G, Brenner CA, Hetrick WP, Merrill CC, Shekhar A, O'Donnell BF. 2010. Auditory steady state response in bipolar disorder: Relation to clinical state, cognitive performance, medication status, and substance disorders. Bipolar Disord 12:(8):793-803.
38. Roach BJ, Ford JM, Hoffman RE, Mathalon DH. 2013. Converging evidence for gamma synchrony deficits in schizophrenia. Suppl Clin Neurophysiol 62: 163-180.
39. Ross AS, Hunter SK, Groth MA, Ross RG. 2013a. P50 sensory gating in infants. J Vis Exp 82:(e50065):1-5.
40. Ross RG, Hunter SK, McCarthy L, Beuler J, Hutchison AK, Wagner BD, Leonard S, Stevens KE, Freedman R. 2013b. Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk. Am J Psychiatry 170:(3):290-298.
41. Rotaru DC, Lewis DA, Gonzalez-Burgos G. 2012. The role of glutamatergic inputs onto parvalbumin-positive interneurons: Relevance for schizophrenia. Rev Neurosci 23:(1):97-109.
42. Salisbury DF, Shenton ME, McCarley RW. 1999. P300 topography differs in schizophrenia and manic psychosis. Biol Psychiatry 45:(1):98-106.
43. Sanchez-Morla EM, Garcia-Jimenez MA, Barabash A, Martinez-Vizcaino V, Mena J, Cabranes-Diaz JA, Baca-Baldomero E, Santos JL. 2008. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr Scandinavica 117:(4):313-318.
44. Schizophrenia Working Group of the Psychiatric Genomics C. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:(7510):421-427.
45. Schulze K, Hall MH, McDonald C, Bramon E, Marshall N, Walshe M, Murray R. 2008. Auditory P300 in patients with bipolar disorder and their unaffected relatives. Bipolar Disord 10:(3):377-386.
46. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N, Edenberg HJ, Nurnberger JI, Jr., Rietschel M, Blackwood D, Corvin A, Flickinger M, Guan W, Mattingsdal M, McQuillin A, Kwan P, Wienker TF, Daly M, Dudbridge F, Holmans PA, Lin D, Burmeister M, Greenwood TA, Hamshere ML, Muglia P, Smith EN, Zandi PP, Nievergelt CM, McKinney R, Shilling PD, Schork NJ, Bloss CS, Foroud T, Koller DL, Gershon ES, Liu C, Badner JA, Scheftner WA, Lawson WB, Nwulia EA, Hipolito M, Coryell W, Rice J, Byerley W, McMahon FJ, Schulze TG, Berrettini W, Lohoff FW, Potash JB, Mahon PB, McInnis MG, Zollner S, Zhang P, Craig DW, Szelinger S, Barrett TB, Breuer R, Meier S, Strohmaier J, Witt SH, Tozzi F, Farmer A, McGuffin P, Strauss J, Xu W, Kennedy JL, Vincent JB, Matthews K, Day R, Ferreira MA, O'Dushlaine C, Perlis R, Raychaudhuri S, Ruderfer D, Hyoun PL, Smoller JW, Li J, Absher D, Thompson RC, Meng FG, Schatzberg AF, Bunney WE, Barchas JD, Jones EG, Watson SJ, Myers RM, Akil H, Boehnke M, Chambert K, Moran J, Scolnick E, Djurovic S, Melle I, Morken G, Gill M, Morris D, Quinn E, Muhleisen TW, Degenhardt FA, Mattheisen M, Schumacher J, Maier W, Steffens M, Propping P, Nothen MM, Anjorin A, Bass N, Gurling H, Kandaswamy R, Lawrence J, McGhee K, McIntosh A, McLean AW, Muir WJ, Pickard BS, Breen G, St Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Jones IR, Kirov G, Moskvina V, Nikolov I, O'Donovan MC, Owen MJ, Collier DA, Elkin A, Williamson R, Young AH, Ferrier IN, Stefansson K, Stefansson H, Thornorgeirsson T, Steinberg S, Gustafsson O, Bergen SE, Nimgaonkar V, Hultman C, Landen M, Lichtenstein P, Sullivan P, Schalling M, Osby U, Backlund L, Frisen L, Langstrom N, Jamain S, Leboyer M, Etain B, Bellivier F, Petursson H, Sigur Sson E, Muller-Mysok B, Lucae S, Schwarz M, Schofield PR, Martin N, Montgomery GW, Lathrop M, Oskarsson H, Bauer M, Wright A, Mitchell PB, Hautzinger M, Reif A, Kelsoe JR, Purcell SM. 2011. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43:(10):977-983.
47. Spencer KM, Niznikiewicz MA, Nestor PG, Shenton ME, McCarley RW. 2009. Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia. BMC Neurosci 10:85.
48. Spencer KM, Niznikiewicz MA, Shenton ME, McCarley RW. 2008a. Sensory-evoked gamma oscillations in chronic schizophrenia. Biol Psychiatry 63:(8):744-747.
49. Spencer KM, Salisbury DF, Shenton ME, McCarley RW. 2008b. Gamma-band auditory steady-state responses are impaired in first episode psychosis. Biol Psychiatry 64:369-375.
50. Stephens SH, Logel J, Barton A, Franks A, Schultz J, Short M, Dickenson J, James B, Fingerlin TE, Wagner B, Hodgkinson C, Graw S, Ross RG, Freedman R, Leonard S. 2009. Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophr Res 109:(1-3):102-112.
51. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. 2007. Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophr Bull 33:(1):69-94.
52. Uhlhaas PJ, Singer W. 2010. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11:(2):100-113.
53. Uhlhaas PJ, Singer W. 2013. High-frequency oscillations and the neurobiology of schizophrenia. Dialogues Clin Neurosci 15:(3):301-313.
54. Wang Q, Xiang B, Deng W, Wu J, Li M, Ma X, Wang Y, Jiang L, McAlonan G, Chua SE, Sham PC, Hu X, Li T. 2013. Genome-wide association analysis with gray matter volume as a quantitative phenotype in first-episode treatment-naive patients with schizophrenia. PloS one 8:(9):e75083.
55. Yamagishi S, Hampel F, Hata K, Del Toro D, Schwark M, Kvachnina E, Bastmeyer M, Yamashita T, Tarabykin V, Klein R, Egea J. 2011. FLRT2 and FLRT3 act as repulsive guidance cues for Unc5-positive neurons. The EMBO journal 30:(14):2920-2933.